首页 > 最新文献

Tissue & cell最新文献

英文 中文
Dual actions of apelin-13 in TNBS-induced colitis: Colonic protection via the gut–liver axis but intrinsic hepatotoxic potential following systemic administration apelin-13在tnbs诱导的结肠炎中的双重作用:通过肠-肝轴进行结肠保护,但在全身给药后具有内在的肝毒性潜力。
IF 2.5 4区 生物学 Q1 ANATOMY & MORPHOLOGY Pub Date : 2025-12-12 DOI: 10.1016/j.tice.2025.103276
Ilknur Birsen , Kamil Erdogan , Ozlem Ozsoy , Sevil Aksu , Ozlem Ozbey Unlu , Gizem Korkmaz , Vecihe Nimet Izgut-Uysal
Inflammatory bowel disease (IBD) is a systemic condition that can also lead to extraintestinal complications, including liver damage. Disruptions in the gut–liver axis and inflammatory mediators play a key role in this process. Apelin, a peptide involved in inflammation, oxidative stress, and apoptosis, has shown protective effects in the colon during IBD; however, its hepatic actions remain unclear, making it crucial to clarify its systemic impact on the gut–liver axis.
This study aimed to evaluate the effects of apelin-13 on liver injury associated with colitis using a trinitrobenzene sulfonic acid (TNBS)-induced colitis model. Wistar rats were divided into five groups (n = 8 per group): normal control (NC), ethanol control (EC), apelin (AP), colitis (TNB), and colitis + apelin (TNB+AP). Colitis was induced via intrarectal administration of TNBS (100 mg/kg in 50 % ethanol), and apelin-13 (150 µg/kg/day, i.p.) was administered for three days following induction.
Apelin-13 reduced colitis severity, by reducing weight loss, colon damage, and disease activity index (DAI), and improved intestinal barrier integrity by increasing zonula occludens-1 (ZO-1) expression, thereby reducing portal tumor necrosis factor (TNF-α) and lipopolysaccharide (LPS) levels. However, apelin-13 did not prevent TNBS-induced hepatic inflammation or oxidative stress and, when administered alone, caused mild hepatocellular injury, with increased necrosis, TNF-α, malondialdehyde (MDA), and alanine aminotransferase (ALT) levels.
In conclusion, apelin-13 ameliorates colitis and modulates gut–liver axis signaling but fails to confer hepatic protection. This outcome suggests that gut-mediated benefits may be offset by mild hepatic stress caused by systemic apelin exposure, resulting in a neutral overall liver response. These findings emphasize that apelin-based interventions in IBD may require targeted delivery strategies to retain intestinal benefits while minimizing hepatic exposure.
炎症性肠病(IBD)是一种全身性疾病,也可导致肠外并发症,包括肝损伤。肠肝轴和炎症介质的破坏在这一过程中起关键作用。Apelin是一种参与炎症、氧化应激和细胞凋亡的肽,在IBD期间显示出对结肠的保护作用;然而,其肝脏作用尚不清楚,因此阐明其对肠-肝轴的系统性影响至关重要。本研究旨在通过三硝基苯磺酸(TNBS)诱导的结肠炎模型,评估apelin-13对结肠炎肝损伤的影响。Wistar大鼠分为5组(每组 = 8只):正常对照组(NC)、乙醇对照组(EC)、apelin (AP)、结肠炎(TNB)和结肠炎+ apelin (TNB+AP)。通过直肠内给药TNBS(100 mg/kg, 50% %乙醇)诱导结肠炎,诱导后三天给药apelin-13(150 µg/kg/天,i.p.)。Apelin-13通过减轻体重、结肠损伤和疾病活动指数(DAI)来减轻结肠炎的严重程度,并通过增加封闭带-1 (ZO-1)的表达从而降低门静脉肿瘤坏死因子(TNF-α)和脂多糖(LPS)水平来改善肠屏障的完整性。然而,apelin-13并不能预防tnbs诱导的肝脏炎症或氧化应激,当单独给药时,引起轻度肝细胞损伤,坏死、TNF-α、丙二醛(MDA)和丙氨酸转氨酶(ALT)水平升高。综上所述,apelin-13改善结肠炎并调节肠-肝轴信号,但不能赋予肝脏保护作用。这一结果表明,肠道介导的益处可能被全身apelin暴露引起的轻度肝脏应激所抵消,从而导致中性的整体肝脏反应。这些发现强调,基于apelin的IBD干预可能需要有针对性的递送策略,以保持肠道益处,同时最大限度地减少肝脏暴露。
{"title":"Dual actions of apelin-13 in TNBS-induced colitis: Colonic protection via the gut–liver axis but intrinsic hepatotoxic potential following systemic administration","authors":"Ilknur Birsen ,&nbsp;Kamil Erdogan ,&nbsp;Ozlem Ozsoy ,&nbsp;Sevil Aksu ,&nbsp;Ozlem Ozbey Unlu ,&nbsp;Gizem Korkmaz ,&nbsp;Vecihe Nimet Izgut-Uysal","doi":"10.1016/j.tice.2025.103276","DOIUrl":"10.1016/j.tice.2025.103276","url":null,"abstract":"<div><div>Inflammatory bowel disease (IBD) is a systemic condition that can also lead to extraintestinal complications, including liver damage. Disruptions in the gut–liver axis and inflammatory mediators play a key role in this process. Apelin, a peptide involved in inflammation, oxidative stress, and apoptosis, has shown protective effects in the colon during IBD; however, its hepatic actions remain unclear, making it crucial to clarify its systemic impact on the gut–liver axis.</div><div>This study aimed to evaluate the effects of apelin-13 on liver injury associated with colitis using a trinitrobenzene sulfonic acid (TNBS)-induced colitis model. Wistar rats were divided into five groups (n = 8 per group): normal control (NC), ethanol control (EC), apelin (AP), colitis (TNB), and colitis + apelin (TNB+AP). Colitis was induced via intrarectal administration of TNBS (100 mg/kg in 50 % ethanol), and apelin-13 (150 µg/kg/day, i.p.) was administered for three days following induction.</div><div>Apelin-13 reduced colitis severity, by reducing weight loss, colon damage, and disease activity index (DAI), and improved intestinal barrier integrity by increasing zonula occludens-1 (ZO-1) expression, thereby reducing portal tumor necrosis factor (TNF-α) and lipopolysaccharide (LPS) levels. However, apelin-13 did not prevent TNBS-induced hepatic inflammation or oxidative stress and, when administered alone, caused mild hepatocellular injury, with increased necrosis, TNF-α, malondialdehyde (MDA), and alanine aminotransferase (ALT) levels.</div><div>In conclusion, apelin-13 ameliorates colitis and modulates gut–liver axis signaling but fails to confer hepatic protection. This outcome suggests that gut-mediated benefits may be offset by mild hepatic stress caused by systemic apelin exposure, resulting in a neutral overall liver response. These findings emphasize that apelin-based interventions in IBD may require targeted delivery strategies to retain intestinal benefits while minimizing hepatic exposure.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103276"},"PeriodicalIF":2.5,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145775928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mast cell characterization, density, and distribution in placenta accreta spectrum: A histological, histochemical and immunohistochemical analysis 肥大细胞的特征,密度和分布在胎盘增生光谱:组织学,组织化学和免疫组织化学分析。
IF 2.5 4区 生物学 Q1 ANATOMY & MORPHOLOGY Pub Date : 2025-12-11 DOI: 10.1016/j.tice.2025.103273
Thaer Bahjat , Malak AL-Yawer , Haydar Al- Shamaa
The placenta accreta spectrum (PAS) is a group of disorders characterized by abnormal trophoblastic invasion, often associated with decidual defects, stromal remodeling, and immune dysregulation, resulting in serious obstetric complications. Mast cells (MCs), known for their roles in tissue remodeling, angiogenesis, and inflammation, have not been fully explored in the context of PAS. This study aimed to investigate the morphological, phenotypic, and quantitative alterations of MCs in PAS compared to normal placentas using a multimodal histopathological approach. Placental tissues from PAS cases and gestational age-matched controls were examined using hematoxylin and eosin (H&E), toluidine blue (TB), Alcian blue/safranin (A/S), and immunohistochemistry (IHC) with anti-tryptase antibodies. MC density, distribution, morphology, and activation status were assessed in the decidual, villous, and myometrial compartments and statistical comparisons were made using t-tests and two-way ANOVA. The results showed a significant increase in MC density in PAS placentas across all staining methods (p < 0.05). Histochemical stains revealed a greater number of morphologically activated MCs, particularly connective tissue-type mast cells (CTMCs), in PAS tissues. IHC confirmed elevated counts of tryptase-positive MCs exhibiting features of degranulation, especially in areas adjacent to trophoblastic invasion and stromal disruption. Statistical analysis indicated a significant effect of both diagnosis and staining technique on MC counts (p < 0.001). These findings suggest that MCs are increased and activated in PAS, with potential roles in extracellular matrix (ECM) degradation, inflammation, and abnormal implantation. The predominance of CTMCs and their spatial association with invasive extravillous trophoblasts point to a contributory role in PAS pathophysiology. Further research using expanded immunomarker panels, functional assays, and more diverse study populations is needed to determine whether MCs are causal agents or secondary responders in PAS and to assess their potential as diagnostic or therapeutic targets.
胎盘增生谱(PAS)是一组以滋养细胞异常侵袭为特征的疾病,常伴有蜕膜缺陷、间质重塑和免疫失调,可导致严重的产科并发症。肥大细胞(MCs)以其在组织重塑、血管生成和炎症中的作用而闻名,但在PAS的背景下尚未得到充分的探讨。本研究旨在利用多模态组织病理学方法研究PAS中MCs与正常胎盘的形态学、表型和定量变化。采用苏木精和伊红(H&E)、甲苯胺蓝(TB)、阿利新蓝/红花红(A/S)和抗胰蛋白酶抗体免疫组化(IHC)检测PAS病例和胎龄匹配对照组的胎盘组织。在蜕膜室、绒毛室和肌层室中评估MC密度、分布、形态和激活状态,并使用t检验和双向方差分析进行统计比较。结果显示,在所有染色方法中,PAS胎盘的MC密度都显著增加(p
{"title":"Mast cell characterization, density, and distribution in placenta accreta spectrum: A histological, histochemical and immunohistochemical analysis","authors":"Thaer Bahjat ,&nbsp;Malak AL-Yawer ,&nbsp;Haydar Al- Shamaa","doi":"10.1016/j.tice.2025.103273","DOIUrl":"10.1016/j.tice.2025.103273","url":null,"abstract":"<div><div>The placenta accreta spectrum (PAS) is a group of disorders characterized by abnormal trophoblastic invasion, often associated with decidual defects, stromal remodeling, and immune dysregulation, resulting in serious obstetric complications. Mast cells (MCs), known for their roles in tissue remodeling, angiogenesis, and inflammation, have not been fully explored in the context of PAS. This study aimed to investigate the morphological, phenotypic, and quantitative alterations of MCs in PAS compared to normal placentas using a multimodal histopathological approach. Placental tissues from PAS cases and gestational age-matched controls were examined using hematoxylin and eosin (H&amp;E), toluidine blue (TB), Alcian blue/safranin (A/S), and immunohistochemistry (IHC) with anti-tryptase antibodies. MC density, distribution, morphology, and activation status were assessed in the decidual, villous, and myometrial compartments and statistical comparisons were made using t-tests and two-way ANOVA. The results showed a significant increase in MC density in PAS placentas across all staining methods (p &lt; 0.05). Histochemical stains revealed a greater number of morphologically activated MCs, particularly connective tissue-type mast cells (CTMCs), in PAS tissues. IHC confirmed elevated counts of tryptase-positive MCs exhibiting features of degranulation, especially in areas adjacent to trophoblastic invasion and stromal disruption. Statistical analysis indicated a significant effect of both diagnosis and staining technique on MC counts (p &lt; 0.001). These findings suggest that MCs are increased and activated in PAS, with potential roles in extracellular matrix (ECM) degradation, inflammation, and abnormal implantation. The predominance of CTMCs and their spatial association with invasive extravillous trophoblasts point to a contributory role in PAS pathophysiology. Further research using expanded immunomarker panels, functional assays, and more diverse study populations is needed to determine whether MCs are causal agents or secondary responders in PAS and to assess their potential as diagnostic or therapeutic targets.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103273"},"PeriodicalIF":2.5,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145794910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Membrane-engineered Wharton’s Jelly derived mesenchymal stem cells with anti-CD2 antibody coating modulate activated CD3+ T-cell responses 膜工程沃顿果冻衍生的间充质干细胞具有抗cd2抗体涂层,可调节活化的CD3+ t细胞反应。
IF 2.5 4区 生物学 Q1 ANATOMY & MORPHOLOGY Pub Date : 2025-12-10 DOI: 10.1016/j.tice.2025.103274
Hilal Özçelik , Yusufhan Yazır , Gökhan Duruksu , Kamil Can Kılıç , Ahmet Öztürk

Objective

Mesenchymal stem cells (MSCs) regulate immunity through paracrine signaling and direct interactions by secreting cytokines and biological factors, yet effective therapy requires large numbers of MSCs. This study aimed to improve the interaction between human Wharton’s Jelly-derived mesenchymal stem cells (hWJ-MSCs) and activated CD2⁺/CD3⁺ T lymphocytes by incorporating anti-CD2 antibodies into their cell membranes. This strategy was grounded in the recognition that MSC immunoregulatory efficacy depends on both soluble mediators and receptor-mediated cell-cell contact, and that strengthening this interface enhances their functional engagement with activated T-cells.

Methods

In this study, hWJ-MSCs were coated with a palmitic acid-conjugated protein G (PPG) system to anchor anti-CD2 antibodies onto the cell membrane. Cytocompatibility of coating was evaluated using WST-8 assay, and 20 µg/mL was identified as optimal concentration. After coating and T-cell isolation, a 48-hour co-culture was established with phytohemagglutinin (PHA)-stimulated CD2⁺/CD3⁺ T lymphocytes and β-cells. Cellular responses were evaluated using WST-8, Live/Dead staining, CFSE proliferation assay, DCFDA-based ROS analysis, and CD3 flow cytometry to assess viability, proliferation, and oxidative activity of PBMCs. β-cell function was assessed by measuring insulin secretion using a single ELISA assay as a functional outcome indicator, without further mechanistic analysis.

Results

The WST-8 assay demonstrated that 20 µg/mL PPG maintained approximately 80 % cell viability, and this concentration was selected as the optimal dose for subsequent experiments. Anti-CD2 and anti-PPG antibodies were purified using the FPLC method. CD25 and CD2 marker expression increased following PHA stimulation. CFSE staining showed higher fluorescence intensity in the MSC-coated group than in the non-coated group, indicating suppressed T-cell proliferation. DCFDA staining revealed reduced ROS levels in the coated group, while the WST-8 test indicated lower viability in MSC-coated groups relative to controls. ELISA analysis showed the highest insulin secretion in the MSC-coated group.

Conclusion

Anti-CD2 antibody-conjugated PPG-coated hWJ-MSCs reduced T-cell viability, proliferation, and WST-8-based metabolic activity while also attenuating DCFDA-detected ROS compared with uncoated cells. ROS levels remained elevated in CD2-only group. Coated MSCs therefore produced a more controlled and less inflammatory T-cell response within co-culture system. These findings suggest that surface-engineered hWJ-MSCs may enhance immunoregulatory performance of MSC-based approaches for T-cell-mediated autoimmune disorders, including Type 1 Diabetes Mellitus (T1DM).
目的:间充质干细胞(Mesenchymal stem cells, MSCs)通过分泌旁分泌信号并通过分泌细胞因子和生物因子直接相互作用调节免疫,但有效的治疗需要大量的间充质干细胞。该研究旨在通过将抗CD2抗体掺入活化的CD2 + /CD3 + T淋巴细胞的细胞膜,改善人类沃顿氏果冻源间充质干细胞(hWJ-MSCs)与CD2 + /CD3 + T淋巴细胞之间的相互作用。这一策略的基础是认识到间充质干细胞的免疫调节功效取决于可溶性介质和受体介导的细胞-细胞接触,加强这种界面可以增强它们与活化t细胞的功能结合。方法:采用棕榈酸偶联蛋白G (PPG)系统包被hWJ-MSCs,将抗cd2抗体固定在细胞膜上。采用WST-8法评价包被的细胞相容性,以20 µg/mL为最佳浓度。包被和T细胞分离后,用植物血凝素(PHA)刺激的CD2 + /CD3 + T淋巴细胞和β-细胞共培养48小时。采用WST-8、活/死染色、CFSE增殖试验、基于dcfda的ROS分析和CD3流式细胞术评估PBMCs的活力、增殖和氧化活性。β细胞的功能是通过测量胰岛素分泌来评估的,使用单一的酶联免疫吸附试验作为功能结局指标,没有进一步的机制分析。结果:WST-8实验表明,20 µg/mL PPG可维持约80 %的细胞活力,该浓度被选为后续实验的最佳剂量。用FPLC法纯化抗cd2和抗ppg抗体。PHA刺激后CD25和CD2标记物表达增加。CFSE染色显示,msc包被组的荧光强度高于未包被组,表明t细胞增殖受到抑制。DCFDA染色显示包被组ROS水平降低,WST-8检测显示msc包被组的细胞活力低于对照组。ELISA分析显示,mscs包被组胰岛素分泌最高。结论:与未包被的细胞相比,抗cd2抗体结合ppg包被的hWJ-MSCs降低了t细胞的活力、增殖和wst -8代谢活性,同时也减弱了dcfda检测到的ROS。仅cd2组ROS水平升高。因此,包被的间充质干细胞在共培养系统中产生了更可控和更少的炎性t细胞反应。这些发现表明,表面工程的hWJ-MSCs可以增强基于mscs的方法对t细胞介导的自身免疫性疾病(包括1型糖尿病)的免疫调节性能。
{"title":"Membrane-engineered Wharton’s Jelly derived mesenchymal stem cells with anti-CD2 antibody coating modulate activated CD3+ T-cell responses","authors":"Hilal Özçelik ,&nbsp;Yusufhan Yazır ,&nbsp;Gökhan Duruksu ,&nbsp;Kamil Can Kılıç ,&nbsp;Ahmet Öztürk","doi":"10.1016/j.tice.2025.103274","DOIUrl":"10.1016/j.tice.2025.103274","url":null,"abstract":"<div><h3>Objective</h3><div>Mesenchymal stem cells (MSCs) regulate immunity through paracrine signaling and direct interactions by secreting cytokines and biological factors, yet effective therapy requires large numbers of MSCs. This study aimed to improve the interaction between human Wharton’s Jelly-derived mesenchymal stem cells (hWJ-MSCs) and activated CD2⁺/CD3⁺ T lymphocytes by incorporating anti-CD2 antibodies into their cell membranes. This strategy was grounded in the recognition that MSC immunoregulatory efficacy depends on both soluble mediators and receptor-mediated cell-cell contact, and that strengthening this interface enhances their functional engagement with activated T-cells.</div></div><div><h3>Methods</h3><div>In this study, hWJ-MSCs were coated with a palmitic acid-conjugated protein G (PPG) system to anchor anti-CD2 antibodies onto the cell membrane. Cytocompatibility of coating was evaluated using WST-8 assay, and 20 µg/mL was identified as optimal concentration. After coating and T-cell isolation, a 48-hour co-culture was established with phytohemagglutinin (PHA)-stimulated CD2⁺/CD3⁺ T lymphocytes and β-cells. Cellular responses were evaluated using WST-8, Live/Dead staining, CFSE proliferation assay, DCFDA-based ROS analysis, and CD3 flow cytometry to assess viability, proliferation, and oxidative activity of PBMCs. β-cell function was assessed by measuring insulin secretion using a single ELISA assay as a functional outcome indicator, without further mechanistic analysis.</div></div><div><h3>Results</h3><div>The WST-8 assay demonstrated that 20 µg/mL PPG maintained approximately 80 % cell viability, and this concentration was selected as the optimal dose for subsequent experiments. Anti-CD2 and anti-PPG antibodies were purified using the FPLC method. CD25 and CD2 marker expression increased following PHA stimulation. CFSE staining showed higher fluorescence intensity in the MSC-coated group than in the non-coated group, indicating suppressed T-cell proliferation. DCFDA staining revealed reduced ROS levels in the coated group, while the WST-8 test indicated lower viability in MSC-coated groups relative to controls. ELISA analysis showed the highest insulin secretion in the MSC-coated group.</div></div><div><h3>Conclusion</h3><div>Anti-CD2 antibody-conjugated PPG-coated hWJ-MSCs reduced T-cell viability, proliferation, and WST-8-based metabolic activity while also attenuating DCFDA-detected ROS compared with uncoated cells. ROS levels remained elevated in CD2-only group. Coated MSCs therefore produced a more controlled and less inflammatory T-cell response within co-culture system. These findings suggest that surface-engineered hWJ-MSCs may enhance immunoregulatory performance of MSC-based approaches for T-cell-mediated autoimmune disorders, including Type 1 Diabetes Mellitus (T1DM).</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103274"},"PeriodicalIF":2.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145744744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Niaodukang for the treatment of chronic kidney disease: Regulation of the TRAF3/NF-κB2 signaling pathway and its improvement of the intestinal barrier 尿毒康治疗慢性肾病:调节TRAF3/NF-κB2信号通路及其改善肠屏障的作用
IF 2.5 4区 生物学 Q1 ANATOMY & MORPHOLOGY Pub Date : 2025-12-09 DOI: 10.1016/j.tice.2025.103271
Juan Xu , Lei Wang , Hong Wang , Jie Pang , Linna Liu , Ting Zhang , Ling Yuan , Xiaoxue Cui , Qian Jiang , Yanlin Li

Background

Niaodukang (NDK) mixture is a traditional Chinese herbal formula clinically used for chronic kidney disease (CKD). However, its bioactive components and molecular mechanisms remain unclear.

Objective

To explore the protective effect of NDK on CKD-associated intestinal barrier dysfunction and identify its key active compound targeting the TRAF3/NF-κB2 pathway.

Methods

A 5/6 nephrectomy rat model and indole-induced Caco-2 cell injury model were established. Renal function, intestinal tight junction integrity, and inflammatory signaling were evaluated by histological, molecular, and ultrastructural analyses. Network pharmacology and molecular docking were applied to predict bioactive compounds, followed by in vitro validation.

Results

NDK significantly improved renal function (reduced Scr, BUN, and urine protein; P < 0.01) and restored intestinal epithelial barrier integrity, as indicated by increased ZO-1 and occludin expression and improved ultrastructure. Among 126 candidate compounds, formononetin from Astragalus membranaceus exhibited strong binding affinity to TRAF3. Functional assays confirmed that formononetin suppressed TRAF3/NF-κB2 signaling, restored tight junction proteins, and alleviated epithelial injury, whereas TRAF3 overexpression abolished these protective effects.

Conclusion

NDK ameliorates CKD-associated intestinal barrier dysfunction by suppressing the TRAF3/NF-κB2 pathway. Formononetin serves as a principal active compound mediating this effect, elucidating the pharmacological basis of NDK and supporting its therapeutic potential for CKD.
背景:尿毒康(NDK)合剂是临床上用于治疗慢性肾脏病(CKD)的传统中药方剂。然而,其生物活性成分和分子机制尚不清楚。目的:探讨NDK对ckd相关肠屏障功能障碍的保护作用,并鉴定其靶向TRAF3/NF-κB2通路的关键活性化合物。方法:建立5/6肾切除大鼠模型和吲哚诱导Caco-2细胞损伤模型。通过组织学、分子和超微结构分析评估肾功能、肠紧密连接完整性和炎症信号。应用网络药理学和分子对接技术预测活性化合物,并进行体外验证。结果:NDK可显著改善肾功能(降低Scr、BUN和尿蛋白);P 结论:NDK可通过抑制TRAF3/NF-κB2通路改善ckd相关肠屏障功能障碍。刺芒柄花素是介导这一作用的主要活性化合物,阐明了NDK的药理学基础,并支持其治疗慢性肾病的潜力。
{"title":"Niaodukang for the treatment of chronic kidney disease: Regulation of the TRAF3/NF-κB2 signaling pathway and its improvement of the intestinal barrier","authors":"Juan Xu ,&nbsp;Lei Wang ,&nbsp;Hong Wang ,&nbsp;Jie Pang ,&nbsp;Linna Liu ,&nbsp;Ting Zhang ,&nbsp;Ling Yuan ,&nbsp;Xiaoxue Cui ,&nbsp;Qian Jiang ,&nbsp;Yanlin Li","doi":"10.1016/j.tice.2025.103271","DOIUrl":"10.1016/j.tice.2025.103271","url":null,"abstract":"<div><h3>Background</h3><div>Niaodukang (NDK) mixture is a traditional Chinese herbal formula clinically used for chronic kidney disease (CKD). However, its bioactive components and molecular mechanisms remain unclear.</div></div><div><h3>Objective</h3><div>To explore the protective effect of NDK on CKD-associated intestinal barrier dysfunction and identify its key active compound targeting the TRAF3/NF-κB2 pathway.</div></div><div><h3>Methods</h3><div>A 5/6 nephrectomy rat model and indole-induced Caco-2 cell injury model were established. Renal function, intestinal tight junction integrity, and inflammatory signaling were evaluated by histological, molecular, and ultrastructural analyses. Network pharmacology and molecular docking were applied to predict bioactive compounds, followed by in vitro validation.</div></div><div><h3>Results</h3><div>NDK significantly improved renal function (reduced Scr, BUN, and urine protein; <em>P</em> &lt; 0.01) and restored intestinal epithelial barrier integrity, as indicated by increased ZO-1 and occludin expression and improved ultrastructure. Among 126 candidate compounds, formononetin from Astragalus membranaceus exhibited strong binding affinity to TRAF3. Functional assays confirmed that formononetin suppressed TRAF3/NF-κB2 signaling, restored tight junction proteins, and alleviated epithelial injury, whereas TRAF3 overexpression abolished these protective effects.</div></div><div><h3>Conclusion</h3><div>NDK ameliorates CKD-associated intestinal barrier dysfunction by suppressing the TRAF3/NF-κB2 pathway. Formononetin serves as a principal active compound mediating this effect, elucidating the pharmacological basis of NDK and supporting its therapeutic potential for CKD.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103271"},"PeriodicalIF":2.5,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145769233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Black tea extract exerts a protective effect on diethylnitrosamine-induced hepatic precancerous lesions through the Nrf2 signaling pathway 红茶提取物通过Nrf2信号通路对二乙基亚硝胺诱导的肝癌前病变具有保护作用。
IF 2.5 4区 生物学 Q1 ANATOMY & MORPHOLOGY Pub Date : 2025-12-09 DOI: 10.1016/j.tice.2025.103260
Xiu Wang , Ying-hao Hu , Jia-jia Luo, Yan Wang

Objective

To investigate the protective effect and mechanism of black tea (BT) extract on diethylnitrosamine (DEN)-induced liver precancerous lesions in rats.

Methods

Fifty male Sprague-Dawley (SD) rats were randomly assigned to five groups: normal control, DEN model, and three black tea extract groups (low, medium, and high dose: DEN+BT-L, DEN+BT-M, DEN+BT-H). The model and treatment groups received DEN (50 mg/kg, i.p.) for 14 weeks, and black tea extract (25, 50, or 100 mg/kg) was administered via gavage. Liver histopathology was evaluated by hematoxylin-eosin (HE) and Masson staining. Serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), alpha-fetoprotein (AFP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) were assessed. Hepatic oxidative stress markers—reactive oxygen species (ROS), superoxide dismutase (SOD), glutathione (GSH), and malondialdehyde (MDA)—were measured. Expression of nuclear factor erythroid 2–related factor 2 (Nrf2), heme oxygenase-1 (HO-1), NAD(P)H quinone dehydrogenase 1 (NQO1), signal transducer and activator of transcription 3 (STAT3), phosphorylated STAT3 (p-STAT3), nuclear factor-kappa B (p65), and phosphorylated p65 (p-p65) was evaluated by Western blot.

Results

Black tea extract alleviated DEN-induced hepatocyte damage, fibrosis, and inflammation. It reduced serum ALT, AST, ALP, AFP, IL-6, and TNF-α levels, decreased ROS and MDA, and increased SOD and GSH levels in a dose-dependent manner (P < 0.05). Nrf2 and HO-1 protein levels were upregulated, while STAT3, p-STAT3, p65, and p-p65 expressions were downregulated. NQO1 expression showed a decreasing trend.

Conclusions

Black tea extract protects against DEN-induced liver precancerous changes by enhancing antioxidant capacity via the Nrf2/HO-1 pathway and inhibiting the NF-κB/STAT3 axis, suggesting its potential in preventing liver carcinogenesis.
目的:探讨红茶(BT)提取物对二乙基亚硝胺(DEN)诱导的大鼠肝脏癌前病变的保护作用及其机制。方法:雄性SD大鼠50只,随机分为正常对照组、DEN模型组和红茶提取物低、中、高剂量组(DEN+BT-L、DEN+BT-M、DEN+BT-H)。模型组和治疗组大鼠ig DEN(50 mg/kg, ig),灌胃红茶提取物(25、50、100 mg/kg),连续14周。采用苏木精-伊红(HE)染色和Masson染色评价肝组织病理学。检测血清丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、碱性磷酸酶(ALP)、甲胎蛋白(AFP)、白细胞介素-6 (IL-6)、肿瘤坏死因子-α (TNF-α)水平。测定肝脏氧化应激标志物——活性氧(ROS)、超氧化物歧化酶(SOD)、谷胱甘肽(GSH)和丙二醛(MDA)。Western blot检测核因子红系2相关因子2 (Nrf2)、血红素加氧酶1 (HO-1)、NAD(P)H醌脱氢酶1 (NQO1)、转录信号传导激活因子3 (STAT3)、磷酸化STAT3 (P -STAT3)、核因子κ B (p65)、磷酸化p65 (P -p65)的表达。结果:红茶提取物可减轻den诱导的肝细胞损伤、纤维化和炎症。降低血清ALT、AST、ALP、AFP、IL-6和TNF-α水平,降低ROS和MDA水平,升高SOD和GSH水平,且呈剂量依赖性(P )结论:红茶提取物通过Nrf2/HO-1途径增强抗氧化能力,抑制NF-κB/STAT3轴,对den诱导的肝脏癌前病变具有保护作用,提示其具有预防肝癌发生的潜力。
{"title":"Black tea extract exerts a protective effect on diethylnitrosamine-induced hepatic precancerous lesions through the Nrf2 signaling pathway","authors":"Xiu Wang ,&nbsp;Ying-hao Hu ,&nbsp;Jia-jia Luo,&nbsp;Yan Wang","doi":"10.1016/j.tice.2025.103260","DOIUrl":"10.1016/j.tice.2025.103260","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate the protective effect and mechanism of black tea (BT) extract on diethylnitrosamine (DEN)-induced liver precancerous lesions in rats.</div></div><div><h3>Methods</h3><div>Fifty male Sprague-Dawley (SD) rats were randomly assigned to five groups: normal control, DEN model, and three black tea extract groups (low, medium, and high dose: DEN+BT-L, DEN+BT-M, DEN+BT-H). The model and treatment groups received DEN (50 mg/kg, i.p.) for 14 weeks, and black tea extract (25, 50, or 100 mg/kg) was administered via gavage. Liver histopathology was evaluated by hematoxylin-eosin (HE) and Masson staining. Serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), alpha-fetoprotein (AFP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) were assessed. Hepatic oxidative stress markers—reactive oxygen species (ROS), superoxide dismutase (SOD), glutathione (GSH), and malondialdehyde (MDA)—were measured. Expression of nuclear factor erythroid 2–related factor 2 (Nrf2), heme oxygenase-1 (HO-1), NAD(P)H quinone dehydrogenase 1 (NQO1), signal transducer and activator of transcription 3 (STAT3), phosphorylated STAT3 (p-STAT3), nuclear factor-kappa B (p65), and phosphorylated p65 (p-p65) was evaluated by Western blot.</div></div><div><h3>Results</h3><div>Black tea extract alleviated DEN-induced hepatocyte damage, fibrosis, and inflammation. It reduced serum ALT, AST, ALP, AFP, IL-6, and TNF-α levels, decreased ROS and MDA, and increased SOD and GSH levels in a dose-dependent manner (P &lt; 0.05). Nrf2 and HO-1 protein levels were upregulated, while STAT3, p-STAT3, p65, and p-p65 expressions were downregulated. NQO1 expression showed a decreasing trend.</div></div><div><h3>Conclusions</h3><div>Black tea extract protects against DEN-induced liver precancerous changes by enhancing antioxidant capacity via the Nrf2/HO-1 pathway and inhibiting the NF-κB/STAT3 axis, suggesting its potential in preventing liver carcinogenesis.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103260"},"PeriodicalIF":2.5,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145821101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
INHBB promotes liver metastasis of colorectal cancer via regulation of TGF-β/Smad signaling, EMT and anoikis resistance INHBB通过调控TGF-β/Smad信号、EMT和anoikis耐药促进结直肠癌肝转移。
IF 2.5 4区 生物学 Q1 ANATOMY & MORPHOLOGY Pub Date : 2025-12-07 DOI: 10.1016/j.tice.2025.103258
Nianzhao Yang , Dafei Dai , Jun Zhao , Haiyuan Zhao , Haibo Jiang , Jun Liu , Fubao Liu , Xiaopeng Chen

Background

Colorectal cancer (CRC) is the third most prevalent malignancy worldwide, with liver metastasis being a major cause of mortality. Although Inhibin β B (INHBB) is associated with tumor progression, its specific role in CRC liver metastasis remains poorly understood.

Methods

Transcriptomic analysis of GEO/TCGA datasets identified INHBB as a key regulator of anoikis resistance and liver metastasis in colorectal cancer. Comprehensive bioinformatics analyses were performed, including clinicopathological correlation assessment, prognostic evaluation, immune landscape characterization, drug sensitivity prediction, and functional enrichment studies. Functional validation included: (1) molecular profiling (qPCR/Western blot/IHC), (2) siRNA-mediated knockdown in HCT116/Caco-2 cells with functional assays (transwell migration/invasion, calcein AM/EthD-1 anoikis detection), and (3) mechanistic interrogation of TGF-β/Smad signaling, EMT markers, and anoikis-related proteins. In vivo validation was performed using a mouse model with spleen injection.

Results

Our study systematically characterized the expression profile of INHBB in primary CRC and liver metastases, revealing significantly elevated expression in both tissue types (P < 0.01). Clinicopathological analysis demonstrated that high INHBB expression correlated significantly with advanced TNM stage (III-IV), lymph node metastasis (N1–2), and poor prognosis (P < 0.001). Functionally, INHBB knockdown reduced CRC cell migration, invasion, and hepatic metastasis formation (all P < 0.01) through three distinct mechanisms: (1) attenuating TGF-β/Smad2/3/Smad4 signaling (evidenced by decreased Smad2/3 phosphorylation, P < 0.01), (2) reversing EMT progression (E-cadherin upregulation concomitant with N-cadherin and vimentin downregulation), and (3) sensitizing cells to anoikis (INHBB interference significantly increased the anoikis rate). Immune profiling revealed that INHBB positively correlated with M0/M1 macrophages and resting NK cells (P < 0.05), but negatively with resting dendritic cells, mast cells, eosinophils, and plasma cells (P < 0.05), suggesting its potential role in remodeling the immune microenvironment to facilitate tumor immune escape. Our in vivo studies demonstrated that INHBB silencing significantly inhibited colorectal cancer liver metastasis in a xenograft mouse model.

Conclusion

Our study demonstrates that INHBB drives CRC liver metastasis by upregulating the TGF-β/Smad2/3/Smad4 pathway and anoikis resistance, highlighting its potential as a therapeutic target and prognostic biomarker for metastatic CRC.
背景:结直肠癌(CRC)是全球第三大恶性肿瘤,肝转移是导致死亡的主要原因。尽管抑制素β B (INHBB)与肿瘤进展相关,但其在结直肠癌肝转移中的具体作用仍知之甚少。方法:对GEO/TCGA数据集进行转录组学分析,确定INHBB是结直肠癌anoikis耐药和肝转移的关键调节因子。进行了全面的生物信息学分析,包括临床病理相关性评估、预后评估、免疫景观表征、药物敏感性预测和功能富集研究。功能验证包括:(1)分子分析(qPCR/Western blot/IHC), (2) sirna介导的HCT116/ cco -2细胞的功能分析(跨井迁移/侵袭,钙黄蛋白AM/EthD-1 anoikis检测),以及(3)TGF-β/Smad信号,EMT标记和anoikis相关蛋白的机制询问。采用小鼠脾注射模型进行体内验证。结果:我们的研究系统地表征了INHBB在原发性结直肠癌和肝转移中的表达特征,揭示了INHBB在两种组织类型中的表达均显著升高(P )。结论:我们的研究表明,INHBB通过上调TGF-β/Smad2/3/Smad4通路和anoikis耐药性来驱动结直肠癌肝转移,突出了其作为转移性结直肠癌治疗靶点和预后生物标志物的潜力。
{"title":"INHBB promotes liver metastasis of colorectal cancer via regulation of TGF-β/Smad signaling, EMT and anoikis resistance","authors":"Nianzhao Yang ,&nbsp;Dafei Dai ,&nbsp;Jun Zhao ,&nbsp;Haiyuan Zhao ,&nbsp;Haibo Jiang ,&nbsp;Jun Liu ,&nbsp;Fubao Liu ,&nbsp;Xiaopeng Chen","doi":"10.1016/j.tice.2025.103258","DOIUrl":"10.1016/j.tice.2025.103258","url":null,"abstract":"<div><h3>Background</h3><div>Colorectal cancer (CRC) is the third most prevalent malignancy worldwide, with liver metastasis being a major cause of mortality. Although Inhibin β B (INHBB) is associated with tumor progression, its specific role in CRC liver metastasis remains poorly understood.</div></div><div><h3>Methods</h3><div>Transcriptomic analysis of GEO/TCGA datasets identified INHBB as a key regulator of anoikis resistance and liver metastasis in colorectal cancer. Comprehensive bioinformatics analyses were performed, including clinicopathological correlation assessment, prognostic evaluation, immune landscape characterization, drug sensitivity prediction, and functional enrichment studies. Functional validation included: (1) molecular profiling (qPCR/Western blot/IHC), (2) siRNA-mediated knockdown in HCT116/Caco-2 cells with functional assays (transwell migration/invasion, calcein AM/EthD-1 anoikis detection), and (3) mechanistic interrogation of TGF-β/Smad signaling, EMT markers, and anoikis-related proteins. In vivo validation was performed using a mouse model with spleen injection.</div></div><div><h3>Results</h3><div>Our study systematically characterized the expression profile of INHBB in primary CRC and liver metastases, revealing significantly elevated expression in both tissue types (P &lt; 0.01). Clinicopathological analysis demonstrated that high INHBB expression correlated significantly with advanced TNM stage (III-IV), lymph node metastasis (N1–2), and poor prognosis (P &lt; 0.001). Functionally, INHBB knockdown reduced CRC cell migration, invasion, and hepatic metastasis formation (all P &lt; 0.01) through three distinct mechanisms: (1) attenuating TGF-β/Smad2/3/Smad4 signaling (evidenced by decreased Smad2/3 phosphorylation, P &lt; 0.01), (2) reversing EMT progression (E-cadherin upregulation concomitant with N-cadherin and vimentin downregulation), and (3) sensitizing cells to anoikis (INHBB interference significantly increased the anoikis rate). Immune profiling revealed that INHBB positively correlated with M0/M1 macrophages and resting NK cells (P &lt; 0.05), but negatively with resting dendritic cells, mast cells, eosinophils, and plasma cells (P &lt; 0.05), suggesting its potential role in remodeling the immune microenvironment to facilitate tumor immune escape. Our in vivo studies demonstrated that INHBB silencing significantly inhibited colorectal cancer liver metastasis in a xenograft mouse model.</div></div><div><h3>Conclusion</h3><div>Our study demonstrates that INHBB drives CRC liver metastasis by upregulating the TGF-β/Smad2/3/Smad4 pathway and anoikis resistance, highlighting its potential as a therapeutic target and prognostic biomarker for metastatic CRC.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103258"},"PeriodicalIF":2.5,"publicationDate":"2025-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145744738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quercetin targeted NF-κB to regulate platelet activation and prevent arterial thrombosis 槲皮素靶向NF-κB调节血小板活化,预防动脉血栓形成。
IF 2.5 4区 生物学 Q1 ANATOMY & MORPHOLOGY Pub Date : 2025-12-06 DOI: 10.1016/j.tice.2025.103270
Wenli Wang , Yanmei Li , Yanyan Liu , Zhangping Sun , Bingiie Zhao , Fubo Song
While the inactivation effect of quercetin on platelets has been widely studied, the underlying mechanisms remained insufficiently explored. This research examined how quercetin inactivated platelets and helps to prevent thrombosis. We validated quercetin's inhibitory effects on platelet activation by CRP and collagen. We also investigated how quercetin regulated the NF-κB pathway during platelet activation and its potential impact on this process. To validate in vitro results, we created an in vivo arterial thrombus model using FeCl3 and observed thrombus formation after quercetin administration. Quercetin inhibited platelet activation by CRP and collagen, reduced aggregation rate, and suppressed adhesion to collagen surface. This effect was linked to the NF-κB pathway. The in vitro results were validated in a FeCl3-induced carotid artery thrombosis model. The effects of quercetin, as previously mentioned, were observed to be dose-dependent. Furthermore, the essential function of the NF-κB signaling pathway in this process has been substantiated. NF-κB was the drug target of quercetin. However, the inhibitory effect of quercetin was attenuated when the NF-κB pathway was pre-activated. Our study confirmed the antiplatelet and antithrombotic effects of quercetin. This study not only confirmed that quercetin exerted its antithrombotic effects by inhibiting the NF-κB pathway but also, more importantly, clearly identified NF-κB p65 as a direct target of quercetin through molecular docking and DARTS assays.
虽然槲皮素对血小板的失活作用已被广泛研究,但其潜在机制仍未得到充分探讨。这项研究考察了槲皮素如何使血小板失活并帮助预防血栓形成。我们验证了槲皮素对CRP和胶原活化血小板的抑制作用。我们还研究了槲皮素在血小板活化过程中如何调节NF-κB通路及其对这一过程的潜在影响。为了验证体外结果,我们用FeCl3建立了体内动脉血栓模型,观察槲皮素给药后血栓的形成。槲皮素抑制CRP和胶原活化血小板,降低聚集率,抑制胶原表面粘附。这种作用与NF-κB通路有关。体外实验结果在fecl3诱导的颈动脉血栓形成模型中得到验证。槲皮素的作用,如前所述,被观察到是剂量依赖性的。此外,NF-κB信号通路在这一过程中的重要作用已被证实。NF-κB是槲皮素的作用靶点。但预激活NF-κB通路后,槲皮素的抑制作用减弱。我们的研究证实了槲皮素的抗血小板和抗血栓作用。本研究不仅证实了槲皮素通过抑制NF-κB通路发挥抗血栓作用,更重要的是通过分子对接和DARTS实验明确了NF-κB p65是槲皮素的直接靶点。
{"title":"Quercetin targeted NF-κB to regulate platelet activation and prevent arterial thrombosis","authors":"Wenli Wang ,&nbsp;Yanmei Li ,&nbsp;Yanyan Liu ,&nbsp;Zhangping Sun ,&nbsp;Bingiie Zhao ,&nbsp;Fubo Song","doi":"10.1016/j.tice.2025.103270","DOIUrl":"10.1016/j.tice.2025.103270","url":null,"abstract":"<div><div>While the inactivation effect of quercetin on platelets has been widely studied, the underlying mechanisms remained insufficiently explored. This research examined how quercetin inactivated platelets and helps to prevent thrombosis. We validated quercetin's inhibitory effects on platelet activation by CRP and collagen. We also investigated how quercetin regulated the NF-κB pathway during platelet activation and its potential impact on this process. To validate <em>in vitro</em> results, we created an <em>in vivo</em> arterial thrombus model using FeCl<sub>3</sub> and observed thrombus formation after quercetin administration. Quercetin inhibited platelet activation by CRP and collagen, reduced aggregation rate, and suppressed adhesion to collagen surface. This effect was linked to the NF-κB pathway. The <em>in vitro</em> results were validated in a FeCl<sub>3</sub>-induced carotid artery thrombosis model. The effects of quercetin, as previously mentioned, were observed to be dose-dependent. Furthermore, the essential function of the NF-κB signaling pathway in this process has been substantiated. NF-κB was the drug target of quercetin. However, the inhibitory effect of quercetin was attenuated when the NF-κB pathway was pre-activated. Our study confirmed the antiplatelet and antithrombotic effects of quercetin. This study not only confirmed that quercetin exerted its antithrombotic effects by inhibiting the NF-κB pathway but also, more importantly, clearly identified NF-κB p65 as a direct target of quercetin through molecular docking and DARTS assays.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103270"},"PeriodicalIF":2.5,"publicationDate":"2025-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145744696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
U0126 induces osteoclast differentiation via the p38-NFATc-1 signaling pathway U0126通过p38-NFATc-1信号通路诱导破骨细胞分化。
IF 2.5 4区 生物学 Q1 ANATOMY & MORPHOLOGY Pub Date : 2025-12-05 DOI: 10.1016/j.tice.2025.103263
Jiran Wang , Jinan Liu , Xueting Jia , Guangyong Chen , Shuzhen Chen , Xiaofeng Huang
Osteoclast differentiation plays an important role in bone metabolic diseases, such as osteoporosis, osteosclerosis and so on. In the study, we found that the ERK inhibitor, U0126, significantly increased the number of multinucleated osteoclasts after inducing differentiation of mouse mononuclear macrophage RAW264.7 cells. The Shh-p38-NFATc-1 signaling pathway has been reported to induce osteoclast differentiation in our previous work, and here U0126 also could increase pp38 and NFATc-1 expression as well as NFATc-1 entrance into the nucleus. Animal experiment demonstrated that U0126 accelerated tooth eruption in newborn mice and promoted alveolar bone resorption by inducing osteoclastogenesis. Furthermore, U0126 can rescue delayed tooth eruption caused by LDE225 (a Shh inhibitor) suppression of the p38 signaling pathway. Cytological experiments also revealed that U0126 could rescue the osteoclastic inhibitory effect of LDE225, but not Doramapimod (a p38 inhibitor). Therefore, we conclude that U0126 promotes osteoclast differentiation via the p38-NFATc-1 signaling pathway and relieves the inhibitory effect of LDE225 on osteoclastogenesis. Our study may provide a scientific foundation for dental treatment strategies to enhance osteoclast function in addressing tooth eruption issues, such as impacted teeth, delayed eruption of permanent teeth, and cranioclavicular dysplasia syndrome (CCD). It will also serve as a method for future research into novel approaches to treating disorders linked to bone metabolism.
破骨细胞分化在骨质疏松、骨硬化等骨代谢性疾病中起着重要作用。在本研究中,我们发现ERK抑制剂U0126诱导小鼠单核巨噬细胞RAW264.7细胞分化后,明显增加了多核破骨细胞的数量。在我们之前的工作中已经报道了sh -p38-NFATc-1信号通路诱导破骨细胞分化,而U0126也可以增加pp38和NFATc-1的表达以及NFATc-1进入细胞核。动物实验表明,U0126通过诱导破骨细胞生成,加速新生小鼠牙萌出,促进牙槽骨吸收。此外,U0126可以挽救由LDE225(一种Shh抑制剂)抑制p38信号通路引起的延迟出牙。细胞学实验也显示,U0126能恢复LDE225的破骨抑制作用,而对p38抑制剂Doramapimod不起作用。因此,我们认为U0126通过p38-NFATc-1信号通路促进破骨细胞分化,减轻LDE225对破骨细胞发生的抑制作用。本研究可为提高破骨细胞功能,解决埋伏牙、恒牙延迟萌牙、锁骨发育不良综合征(CCD)等牙齿萌牙问题提供科学依据。它还将为未来研究治疗与骨代谢有关的疾病的新方法提供一种方法。
{"title":"U0126 induces osteoclast differentiation via the p38-NFATc-1 signaling pathway","authors":"Jiran Wang ,&nbsp;Jinan Liu ,&nbsp;Xueting Jia ,&nbsp;Guangyong Chen ,&nbsp;Shuzhen Chen ,&nbsp;Xiaofeng Huang","doi":"10.1016/j.tice.2025.103263","DOIUrl":"10.1016/j.tice.2025.103263","url":null,"abstract":"<div><div>Osteoclast differentiation plays an important role in bone metabolic diseases, such as osteoporosis, osteosclerosis and so on. In the study, we found that the ERK inhibitor, U0126, significantly increased the number of multinucleated osteoclasts after inducing differentiation of mouse mononuclear macrophage RAW264.7 cells. The Shh-p38-NFATc-1 signaling pathway has been reported to induce osteoclast differentiation in our previous work, and here U0126 also could increase pp38 and NFATc-1 expression as well as NFATc-1 entrance into the nucleus. Animal experiment demonstrated that U0126 accelerated tooth eruption in newborn mice and promoted alveolar bone resorption by inducing osteoclastogenesis. Furthermore, U0126 can rescue delayed tooth eruption caused by LDE225 (a Shh inhibitor) suppression of the p38 signaling pathway. Cytological experiments also revealed that U0126 could rescue the osteoclastic inhibitory effect of LDE225, but not Doramapimod (a p38 inhibitor). Therefore, we conclude that U0126 promotes osteoclast differentiation via the p38-NFATc-1 signaling pathway and relieves the inhibitory effect of LDE225 on osteoclastogenesis. Our study may provide a scientific foundation for dental treatment strategies to enhance osteoclast function in addressing tooth eruption issues, such as impacted teeth, delayed eruption of permanent teeth, and cranioclavicular dysplasia syndrome (CCD). It will also serve as a method for future research into novel approaches to treating disorders linked to bone metabolism.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103263"},"PeriodicalIF":2.5,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145715934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrastructural configuration of porcine liver preserved by machine perfusion versus static cold storage donated cardiac after death 机器灌注保存的猪肝与静态冷藏的死后捐献心脏超微结构的比较
IF 2.5 4区 生物学 Q1 ANATOMY & MORPHOLOGY Pub Date : 2025-12-05 DOI: 10.1016/j.tice.2025.103262
Hiroki Bochimoto , Nur Khatijah Mohd Zin , Yo Ishihara , Tetsuya Nakajo , Hiromichi Obara , Naoto Matsuno , Daisuke Kondoh
In liver transplantation, it is known that machine perfusion (MP) preservation of liver grafts donated after cardiac death is superior to static cold storage (SCS). However, hepatocyte ultrastructure appears to be normal after SCS, while MP induces significant ultrastructural changes of hepatocytes such as mitochondrial swelling. The differences between these ultrastructural findings and physiological/clinical findings should be evaluated in detail. Here, we examined porcine liver grafts after SCS 4°C or MP at 8°C by osmium-maceration scanning (OM-SEM) and transmission (TEM) electron microscopic analyses. The overall appearance of hepatocytes in the SCS group was relatively normal, while the cytoplasm in the MP group was abnormal with swollen mitochondria and heavily-foamy endoplasmic reticulum. However, bile canaliculi of the liver grafts after SCS were filled with disintegrated materials which represent the exfoliated microvilli, while those after MP had a normal microvilli structure. Liver sinusoidal endothelial cells (LSECs) after SCS showed a heavy cytopathic change accompanied by large vacuoles, whereas LSECs after MP had no or significantly smaller vacuoles that appeared to be autophagosomes. These findings indicated that functional ultrastructure of liver grafts was better preserved in MP condition than in SCS. This is contrary to the impression given by the overall image of hepatocytes, and thus ultrastructural evaluation focusing on specific functional structures like bile canaliculi and LSECs have advantages to of liver grafts. (222/250 words)
在肝移植中,已知心脏死亡后捐献的肝移植物的机器灌注(MP)保存优于静态冷储存(SCS)。然而,SCS后肝细胞超微结构似乎正常,而MP诱导肝细胞超微结构发生明显变化,如线粒体肿胀。应详细评估这些超微结构表现与生理/临床表现之间的差异。在这里,我们通过锇浸渍扫描(OM-SEM)和透射电镜(TEM)分析了4°C SCS或8°C MP后的猪肝移植物。SCS组肝细胞整体外观相对正常,而MP组细胞质异常,线粒体肿胀,内质网大量泡沫。然而,SCS后肝移植物的胆管内充满了崩解的物质,代表脱落的微绒毛,而MP后的肝移植物的微绒毛结构正常。肝窦内皮细胞(LSECs)在SCS后表现出严重的细胞病变,伴有大空泡,而MP后的LSECs没有或明显更小的空泡,似乎是自噬体。这些结果表明,与SCS相比,MP条件下肝移植的功能超微结构得到了更好的保存。这与肝细胞整体图像给人的印象相反,因此关注特定功能结构(如胆管和LSECs)的超微结构评估对肝移植具有优势。(222/250字)
{"title":"Ultrastructural configuration of porcine liver preserved by machine perfusion versus static cold storage donated cardiac after death","authors":"Hiroki Bochimoto ,&nbsp;Nur Khatijah Mohd Zin ,&nbsp;Yo Ishihara ,&nbsp;Tetsuya Nakajo ,&nbsp;Hiromichi Obara ,&nbsp;Naoto Matsuno ,&nbsp;Daisuke Kondoh","doi":"10.1016/j.tice.2025.103262","DOIUrl":"10.1016/j.tice.2025.103262","url":null,"abstract":"<div><div>In liver transplantation, it is known that machine perfusion (MP) preservation of liver grafts donated after cardiac death is superior to static cold storage (SCS). However, hepatocyte ultrastructure appears to be normal after SCS, while MP induces significant ultrastructural changes of hepatocytes such as mitochondrial swelling. The differences between these ultrastructural findings and physiological/clinical findings should be evaluated in detail. Here, we examined porcine liver grafts after SCS 4°C or MP at 8°C by osmium-maceration scanning (OM-SEM) and transmission (TEM) electron microscopic analyses. The overall appearance of hepatocytes in the SCS group was relatively normal, while the cytoplasm in the MP group was abnormal with swollen mitochondria and heavily-foamy endoplasmic reticulum. However, bile canaliculi of the liver grafts after SCS were filled with disintegrated materials which represent the exfoliated microvilli, while those after MP had a normal microvilli structure. Liver sinusoidal endothelial cells (LSECs) after SCS showed a heavy cytopathic change accompanied by large vacuoles, whereas LSECs after MP had no or significantly smaller vacuoles that appeared to be autophagosomes. These findings indicated that functional ultrastructure of liver grafts was better preserved in MP condition than in SCS. This is contrary to the impression given by the overall image of hepatocytes, and thus ultrastructural evaluation focusing on specific functional structures like bile canaliculi and LSECs have advantages to of liver grafts. (222/250 words)</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103262"},"PeriodicalIF":2.5,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145796597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artocarpin alleviates fenofibrate-induced hepatic dysfunction via regulating NLRP3/caspase-1, oxidative stress and bile acids synthesis: A biochemical, histological, and computational investigation Artocarpin通过调节NLRP3/caspase-1、氧化应激和胆胆酸合成来减轻非诺贝特诱导的肝功能障碍:生化、组织学和计算研究
IF 2.5 4区 生物学 Q1 ANATOMY & MORPHOLOGY Pub Date : 2025-12-05 DOI: 10.1016/j.tice.2025.103261
Mohammed S. Alshammari , Salim Jamil , Hafsa Ashfaq , Ahmed Al-Emam , Hesham M. Hassan
Fenofibrate (FBR) is a promising hypolipidemic drug that is reported to induce hepatic impairments. Artocarpin (ACP) is a novel polyphenolic compound with diverse biological properties. This investigation was planned to explore the palliative efficacy of ACP in combating FBR-induced hepatotoxicity. Thirty-two Sprague Dawley rats were grouped into control, FBR (100 mg/kg), FBR (100 mg/kg) + ACP (100 mg/kg), and ACP (100 mg/kg) alone administered group. Our findings showed that FBR intoxication upregulated the mRNA expressions of CXCR4, CCR5, Caspase-1, IL-1β, CCL2, IL-18 and NLRP3. The levels of ROS and MDA were augmented while the enzymatic action of GST, HO-1, SOD, GPx, GSR, GST, and CAT were suppressed following the exposure of FBR. Besides, FBR intoxication induced cholestatic stress as evidenced by elevated levels of chenodeoxycholic, deoxycholic acid, cholic acid, glycocholic acid and taurocholic acid. The levels of ALP, GGT, AST, hepcidin, and ALT were aggravated while the levels of total protein, hemojuvelin, and albumin were inhibited by FBR administration. Moreover, FBR exposure compromised the morphology of liver by altering key structural components. Importantly, concurrent therapy of ACP restored hepatic health by inhibiting the activation of NLRP3/Caspase-1 pathway, reducing hepatic enzymes, oxidative stress while regulating iron metabolism as well as bile acid metabolic alterations. Furthermore, ACP reversed histological alterations in hepatic tissues. These findings are supported by our in-silico analysis which exhibits excellent modulatory activity of ACP by binding at key regulatory binding sites. Collectively, these results underscore the hepatoprotective efficacy of ACP against FBR-induced liver impairments.
非诺贝特(FBR)是一种有前景的降血脂药物,据报道可引起肝损害。阿托卡宾(ACP)是一种具有多种生物学特性的新型多酚类化合物。本研究旨在探讨ACP对fbr肝毒性的缓解作用。将32只Sprague Dawley大鼠分为对照组、FBR(100 mg/kg)、FBR(100 mg/kg) + ACP(100 mg/kg)和ACP(100 mg/kg)单独给药组。结果表明,FBR中毒可上调CXCR4、CCR5、Caspase-1、IL-1β、CCL2、IL-18和NLRP3的mRNA表达。FBR暴露后,ROS和MDA水平升高,GST、HO-1、SOD、GPx、GSR、GST和CAT的酶促作用受到抑制。此外,FBR中毒引起的胆汁抑制应激表现为鹅去氧胆酸、去氧胆酸、胆酸、糖胆酸和牛磺胆酸水平升高。FBR使ALP、GGT、AST、hepcidin、ALT水平升高,抑制总蛋白、血少年蛋白、白蛋白水平。此外,FBR暴露通过改变关键结构成分而损害肝脏形态。重要的是,ACP同时治疗通过抑制NLRP3/Caspase-1通路的激活,减少肝酶,氧化应激,同时调节铁代谢和胆酸代谢改变,恢复肝脏健康。此外,ACP逆转了肝组织的组织学改变。这些发现得到了我们的硅分析的支持,表明ACP通过结合在关键的调节结合位点上表现出良好的调节活性。总之,这些结果强调了ACP对fbr诱导的肝损伤的肝保护作用。
{"title":"Artocarpin alleviates fenofibrate-induced hepatic dysfunction via regulating NLRP3/caspase-1, oxidative stress and bile acids synthesis: A biochemical, histological, and computational investigation","authors":"Mohammed S. Alshammari ,&nbsp;Salim Jamil ,&nbsp;Hafsa Ashfaq ,&nbsp;Ahmed Al-Emam ,&nbsp;Hesham M. Hassan","doi":"10.1016/j.tice.2025.103261","DOIUrl":"10.1016/j.tice.2025.103261","url":null,"abstract":"<div><div>Fenofibrate (FBR) is a promising hypolipidemic drug that is reported to induce hepatic impairments. Artocarpin (ACP) is a novel polyphenolic compound with diverse biological properties. This investigation was planned to explore the palliative efficacy of ACP in combating FBR-induced hepatotoxicity. Thirty-two Sprague Dawley rats were grouped into control, FBR (100 mg/kg), FBR (100 mg/kg) + ACP (100 mg/kg), and ACP (100 mg/kg) alone administered group. Our findings showed that FBR intoxication upregulated the mRNA expressions of CXCR4, CCR5, Caspase-1, IL-1β, CCL2, IL-18 and NLRP3. The levels of ROS and MDA were augmented while the enzymatic action of GST, HO-1, SOD, GPx, GSR, GST, and CAT were suppressed following the exposure of FBR. Besides, FBR intoxication induced cholestatic stress as evidenced by elevated levels of chenodeoxycholic, deoxycholic acid, cholic acid, glycocholic acid and taurocholic acid. The levels of ALP, GGT, AST, hepcidin, and ALT were aggravated while the levels of total protein, hemojuvelin, and albumin were inhibited by FBR administration. Moreover, FBR exposure compromised the morphology of liver by altering key structural components. Importantly, concurrent therapy of ACP restored hepatic health by inhibiting the activation of NLRP3/Caspase-1 pathway, reducing hepatic enzymes, oxidative stress while regulating iron metabolism as well as bile acid metabolic alterations. Furthermore, ACP reversed histological alterations in hepatic tissues. These findings are supported by our in-silico analysis which exhibits excellent modulatory activity of ACP by binding at key regulatory binding sites. Collectively, these results underscore the hepatoprotective efficacy of ACP against FBR-induced liver impairments.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"99 ","pages":"Article 103261"},"PeriodicalIF":2.5,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145747392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Tissue & cell
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1